https://asif.ventures/ https://asif.ventures/getfunded https://asif.ventures/team https://asif.ventures/portfolio https://asif.ventures/team/formerboards https://asif.ventures/team/formerboards/board18-19 https://asif.ventures/team/formerboards/board19-20 https://asif.ventures/team/formerboards/board20-21 https://asif.ventures/team/formerboards/board21-22 https://asif.ventures/team/formerboards/board22-23 https://asif.ventures/team/formerboards/board23-24 https://asif.ventures/team/formerboards/board24-25 https://asif.ventures/team/formerboards/board26-27 https://asif.ventures/xlerate https://asif.ventures/portfolio/pabel-is-an-ai-research-lab-building-foundation-models-for-the-human-brain-trained-on-large-scale-clinical-eeg-data.-its-ai-models-aim-to-turn-complex-neural-activity-into-general-purpose-representations-helping-researchers-identify-biomarkers-of-therapeutic-response-find-patients-more-likely-to-benefit-from-treatment-and-better-understand-how-drugs-affect-brain-function.-with-an-initial-focus-on-cns-drug-development-pabel-seeks-to-advance-precision-neurology-and-psychiatry-while-unlocking-new-possibilities-for-brain-computer-interfaces. https://asif.ventures/portfolio/hearsay https://asif.ventures/portfolio/boomer https://asif.ventures/portfolio/heatliftdynamics https://asif.ventures/portfolio/airweave https://asif.ventures/portfolio/nanoapi https://asif.ventures/portfolio/greencompute https://asif.ventures/portfolio/ziemi https://asif.ventures/portfolio/oasysnow https://asif.ventures/portfolio/reshark https://asif.ventures/portfolio/dropin https://asif.ventures/portfolio/anywyse https://asif.ventures/portfolio/cargoplot https://asif.ventures/portfolio/workwize https://asif.ventures/portfolio/ascenscia https://asif.ventures/portfolio/lalaland https://asif.ventures/portfolio/bluetick https://asif.ventures/portfolio/bringly https://asif.ventures/portfolio/projectcece https://asif.ventures/portfolio/knowork https://asif.ventures/portfolio/dyme